Evidence map›Paper›PMID 31551458›Full record

ArticleScientific reports2019

Association between Diabetes and Keratoconus: A Retrospective Analysis.

Amy E Whelchel, Tina B McKay, Shrestha Priyadarsini, Tyler Rowsey, Dimitrios Karamichos

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Greater exposure to PMScientific reports · 2025
    Article
  3. Review
  4. Article
  5. Systemic and Ocular Associations of Keratoconus.Expert review of ophthalmology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Systemic diseases and the cornea.Experimental eye research · 2021
    Review
  11. Cellular Contractility Profiles of Human Diabetic Corneal Stromal Cells.Analytical cellular pathology (Amsterdam) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amy E WhelchelDepartment of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Tina B McKayDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Shrestha PriyadarsiniDepartment of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Tyler RowseyDepartment of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Dimitrios KaramichosDepartment of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. dimitrios-karamichos@ouhsc.edu.
University of Oklahoma Health Sciences Center · USDean McGee Eye Institute · US

Funding

A Novel Pathogenic Pathway for Diabetic KeratopathyR01EY028949 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Dimitrios Karamichos, Jian-Xing Jay Ma · 2018 to 2026
$2.2M
Sex Hormones and KeratoconusR01EY028888 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI KARAMICHOS, DIMITRIOS · 2018 to 2020
$1.1M
NEI NIH HHS R01 EY028888NEI NIH HHS R01 EY028949U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) EY028888U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) EY028949
6 · The paper itself

Abstract

Keratoconus (KC) and chronic diabetes mellitus (DM) are both associated with significant defects in the human corneal structure. Studies have long suggested that DM is linked to KC, mainly via the crosslinking mechanism, but scientific evidences are lacking. The role of altered systemic metabolism is well-established in both DM and KC with studies suggesting localized altered cellular metabolism leading to the development of corneal pathologies. We have previously characterized the metabolic defects associated with both conditions using targeted metabolomics. To compare metabolic differences between KC and DM-derived corneal fibroblasts, we performed a respective study of two cohorts of the KC and DM populations using a retrospective analysis of targeted metabolomics data. The goal of this study was to identify the group of differentially regulated metabolites, in KC versus DM, so that we may unravel the link between the two devastating corneal pathologies.

Indexed as

CorneaDiabetes ComplicationsDiabetes MellitusFemaleFibroblastsHumansKeratoconusMaleMetabolomicsMiddle AgedRetrospective Studies

Identifiers

PMID31551458
PMCPMC6760226
OpenAlexW2977099974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.